항생제 사용량 변화에 따른 그람음성균주의 항생제 내성률의 변화 양상
The Impact of the Antibiotic Burden on the Selection of its Resistance among Gram Negative Bacteria Isolated from Children
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
목적: 국내 소아 그람음성균혈증에서 항생제 내성변화 및 항생제 사용량과의 관계를 분석하였다. 방법: 최근 10년간 18세 이하 입원 환자의 혈액에서 분리된 그람음성균의 항생제 내성률 변화 및 항생제 사용량과의 관계를 분석하였다. 결과: 폐렴막대균, 대장균, 녹농균, 아시네토박터 바우마니의 분리율은 연간 혈액배양 1,000건당 각각 4.6례, 3.5례, 3.4례 및 2.2례였다. 폐렴막대균에서 광범위 세팔로스포린에 대한 내성변화는 없었으나 2010년부터 카바페넴 내성 폐렴막대균이 동정된 후 점차 빈도가 증가하였다. 대장균의 광범위 세팔로스포린 내성이 10%에서 50%로 아시네토박터 바우마니의 카바페넴 내성이 11%에서 71%로 크게증가하였다(P for trend <0.01). 녹농균은 여러 항생제에 높은 내성을 보였으나 유의한 내성변화를 보이지 않았다. 대장균의 cefepime 내성과 cefepime 사용량 사이에 유의한 양의 상관관계를 보였다(r= 0.900, P =0.037). 결론: 국내 소아에서 발생한 그람음성균 균혈증 분석시 카바페넴 및 광범위 세팔로스포린 내성이 증가하였고 일부에서 항생제 사용량과의 관련성을 확인하였다. 이는 원내 경험적 항생제 결정시 중요한 고려 사항이며 추후에도 지속적인 원내 항생제 사용량 및 내성률에 대한 감시가 필요하겠다.
Abstract
Purpose: We investigated trends in antibiotic pressure and the antibiotic susceptibility of gram negative bacteria isolated from Korean children over 10 consecutive years. Methods: From January 2004 to December 2013, the antibiotic susceptibility of Klebsiella pneumoniae , Escherichia coli , Pseudomonas aeruginosa , and Acinetobacter baumannii blood isolates obtained from children <18 years of age was determined according to the 2009 Clinical and Laboratory Standards Institute guidelines. Antibiotic consumption data were also analyzed. Results: The prevalence of K. pneumoniae , E. coli , P. aeruginosa , and A. baumannii bacteremia was 4.6, 3.5, 3.4, and 2.2 cases/1,000 blood cultures/year, respectively. In K. pneumoniae , resistance to the third and fourth cephalosporin did not increase significantly. However, carbapenem-resistant K. pneumoniae first appeared in 2010, and the resistance rate increased to 9% between 2012 and 2013. Resistance to 3rd and 4th cephalosporin increased from 10% to 50% in E. coli , and resistance to carbapenem rose abruptly from 11% to 71% in A. baumannii (P for trend <0.01). However, such an increase of resistance was not observed in P. aeruginosa . There is a positive correlation between the resistance rate of cefepime in E. coli and the consumption of cefepime (r=0.900, P =0.037). Conclusion: The significant burden of antibiotic consumption and the high prevalence of antibiotic resistance to gram negative pathogen isolated from bacteremic children were observed. Empirical antibiotics should be wisely selected, and continued efforts to decrease the overall antibiotic pressure are mandatory, especially in highly resistant situations.
참고문헌 (35)
- Kumar A, "Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock", Crit Care Med, 34, pp.1589~1596 (2006)
- Hartman ME, "Trends in the epidemiology of pediatric severe sepsis", Pediatr Crit Care Med, 14, pp.686~693 (2013)
- Kang CI, "Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome", Antimicrob Agents Chemother, 49, pp.760~766 (2005)
- Dellinger RP, "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock:2012", Crit Care Med, 41, pp.580~637 (2013)
- 김낙현, "13년간 한 대학병원 혈액배양에서 분리된 균의 분포 및 항생제 감수성 변화 양상", Infection and Chemotherapy, 44(4), pp.275~281 (2012), 대한감염학회
- 강성하, "Characteristics of Microorganisms Isolated from Blood Cultures at a University Hospital Located in an Island Region During 2003∼2007", Annals of Clinical Microbiology, 11(1), pp.11~17 (2008), 대한임상미생물학회
- 김소영, "일개 대학병원의 5년간 혈액 배양에 대한 분석(2003∼2007)", Annals of Clinical Microbiology, 12(4), pp.163~168 (2009), 대한임상미생물학회
- 고은영, "소아 혈액 종양 환자에서 발생한 균혈증의 조사", Infection and Chemotherapy, 43(2), pp.191~197 (2011), 대한감염학회
- 강지은, "최근 5년(2006-2010)간 소아 혈액 종양 환자에서 발생한 균혈증의 원인균 및 임상 양상: 단일기관 연구", Pediatric Infection and Vaccine, 19(3), pp.131~140 (2012), 대한소아감염학회
- Urbanek K, "Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains", J Clin Pharm Ther, 32, pp.403~408 (2007)
- Chaouch C, "Association between bacterial resistance and antimicrobial consumption", Ann Biol Clin, 72, pp.555~560 (2014)
- Sedlakova MH, "Antibiotic consumption and its influence on the resistance in Enterobacteriaceae", BMC Res Notes, 7, pp.454~ (2014)
- Asensio A, "Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010", Euro Surveill, 16 (2011)
- Clinical and Laboratory Standards Institute, "Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement. M100-S19 2009;Vol. 29 No. 3", ~
- Kim YK, "Bloodstream infections by extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome", Antimicrob Agents Chemother, 46, pp.1481~1491 (2002)
- Schwaber MJ, "Clinical and economic impact of bacteremia with extended-spectrum beta-lactamase-producing Enterobacteriaceae", Antimicrob Agents Chemother, 50, pp.1257~1262 (2006)
- Leibovici L, "The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection", J Intern Med, 244, pp.379~386 (1998)
- 김형태, "건강한 소아에서 지역사회 획득 균혈증의 원인균", Korean Journal of Pediatrics, 48(7), pp.716~722 (2005), 대한소아과학회
- 김희정, "Characteristics of Microorganisms Isolated from Blood Cultures at Nine University Hospitals in Korea during 2009", Annals of Clinical Microbiology, 14(2), pp.48~54 (2011), 대한임상미생물학회
- Rhee JY, "KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea", Antimicrob Agents Chemother, 54, pp.2278~2279 (2010)
- Yoo JS, "Detection of clonal KPC-2-producing Klebsiella pneumoniae ST258 in Korea during nationwide surveillance in 2011", J Med Microbiol, 62, pp.1338~1342 (2013)
- Hong SK, "First outbreak of KPC-2-producing Klebsiella pneumoniae sequence type 258 in a hospital in South Korea", J Clin Microbiol, 51, pp.3877~3879 (2013)
- Decousser JW, "Trends in antibiotic susceptibility of bloodstream pathogens in hospitalized patients in France, 1996 to 2007", Diagn Microbiol Infect Dis, 66, pp.292~300 (2010)
- Lee J, "The impact of the increased use of piperacillin", tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella pneumoniae isolates, 2013, pp.17, e638~e643
- 정윤섭, "Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non- Typhoidal Salmonella Species", Infection and Chemotherapy, 46(2), pp.84~93 (2014), 대한감염학회
- 정숙인, "국내 5개 3차 병원의 β-lactam계 항생제 사용 실태 및 Klebsiella pneumoniae의 항생제 내성과의 상관 관계", Infection and Chemotherapy, 39(4), pp.189~195 (2007), 대한감염학회
- Hsueh PR, "Relationships between antimicrobial use and antimicrobial resistance in gramnegative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan", Int J Antimicrob Agents, 26, pp.463~472 (2005)
- 김백남, "우리나라 항생제 사용 실태", Infection and Chemotherapy, 44(4), pp.250~262 (2012), 대한감염학회
- 박실비아, "항생제 사용의 질 지표를 이용한 국내 외래 항생제 사용현황의 국제 비교", 약 학 회 지, 58(3), pp.200~207 (2014), 대한약학회
- Lee J, "Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy", J Antimicrob Chemother, 60, pp.629~637 (2007)
- Du B, "Restriction of third-generation cephalosporin use decreases infectionrelated mortality", Crit Care Med, 31, pp.1088~1093 (2003)
- Meyer E, "Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU", Intensive Care Med, 35, pp.862~870 (2009)
- Sistanizad M, "Carbapenem restriction and its effect on bacterial resistance in an intensive care unit of a teaching hospital", Iran J Pharm Res, 12, pp.503~509 (2013)
- Ntagiopoulos PG, "Impact of an antibiotic restriction policy on the antibiotic resistance patterns of gram-negative microorganisms in an intensive care unit in Greece", Int J Antimicrob Agents, 30, pp.360~365 (2007)
- de Araujo OR, "Cefepime restriction improves gramnegative overall resistance patterns in neonatal intensive care unit", Braz J Infect Dis, 11, pp.277~280 (2007)
